International Flavors (IFF) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 24.36%. A quarter ago, it was expected that this ingredients producer for food, cosmetics and consumer products industries would post earnings of $1.06 per share when it actually produced earnings of $1.04, de ...

Financial Performance - Reported net sales for the full year 2024 were $11.48 billion, flat compared to the prior year, with currency neutral sales increasing by 6%[5] - Adjusted operating EBITDA for the full year was $2.21 billion, reflecting a 16% increase on a comparable basis due to strong volume growth and productivity gains[5] - Reported earnings per share (EPS) for the full year was $0.95, while adjusted EPS excluding amortization was $4.31 per diluted share[5] - For the fourth quarter, reported net sales were $2.77 billion, a 3% increase year-over-year, with currency neutral sales up 6%[8] - Adjusted operating EBITDA for the fourth quarter was $471 million, with a comparable increase of 5% driven by volume growth and productivity gains[10] - Net income for the year ended December 31, 2024, was $247 million, a significant improvement from a net loss of $2,563 million in 2023[42] - Reported (GAAP) Net Income for 2024 was $278 million, a recovery from a net loss of $2,518 million in 2023[68] - Adjusted (Non-GAAP) Net Income for the year ended December 31, 2024, was $646 million, up from $328 million in 2023, representing a growth of 96.34%[70] Segment Performance - The Nourish segment reported a 4% increase in comparable currency neutral sales, while Health & Biosciences and Scent segments saw increases of 6% and 7% respectively[9] - The Nourish segment reported net sales of $5,871 million in 2024, down from $6,060 million in 2023, a decrease of about 3.1%[45] - Health & Biosciences segment sales increased by 6.3% to $2,212 million in 2024, compared to $2,081 million in 2023[84] - Scent segment sales grew to $2,440 million in 2024, up 7.1% from $2,277 million in 2023[84] - Pharma Solutions segment sales reached $961 million in 2024, a slight increase from $945 million in 2023[84] - The company experienced a 12% increase in Pharma Solutions sales, with a remarkable 81% increase in segment adjusted operating EBITDA for Q4 2024[89] Future Projections - Full year 2025 sales are expected to be in the range of $10.6 billion to $10.9 billion, with adjusted operating EBITDA projected between $2 billion and $2.15 billion[12] - The company anticipates comparable currency neutral sales growth of 1% to 4% in 2025, with adjusted operating EBITDA expected to grow 5% to 10% year-over-year[13] - Foreign exchange is expected to have a 4% adverse impact on sales growth and a 6% adverse impact on adjusted operating EBITDA growth in 2025[14] - The Pharma Solutions segment is expected to contribute six months of results in 2025 following its divestiture, which is assumed to close on June 30, 2025[12] Expenses and Cash Flow - Research and development expenses increased by 8% to $170 million in Q4 2024 from $157 million in Q4 2023[38] - Selling and administrative expenses rose by 16% to $517 million in Q4 2024, up from $444 million in Q4 2023[38] - Total net cash provided by operating activities decreased to $1,070 million in 2024 from $1,439 million in 2023, reflecting a decline of approximately 25.6%[42] - The company incurred approximately $1,995 million in Selling and Administrative Expenses for 2024, compared to $1,787 million in 2023, reflecting an increase of 11.65%[65] - Net cash used in financing activities was $1,606 million in 2024, a decrease from $1,851 million in 2023, reflecting a reduction of approximately 13.2%[42] Balance Sheet - Total current assets increased to $7,993 million in 2024 from $6,293 million in 2023[40] - Total liabilities decreased to $14,256 million in 2024 from $15,578 million in 2023[40] - The company’s total assets were $28,667 million in 2024, down from $30,978 million in 2023[40] - Total debt as of December 31, 2024, was $9,005 million, resulting in net debt of $8,534 million after accounting for $471 million in cash and cash equivalents[80] Other Notable Items - The company reported a net loss of $46 million in Q4 2024, a significant improvement from a net loss of $2,609 million in Q4 2023[38] - The company recognized a settlement loss of $130 million related to the termination of the pension plan in 2024[74] - The company incurred an impairment of goodwill of $64 million in 2024, a significant reduction from $2,623 million in 2023[45] - Business divestiture costs for Q4 2024 were approximately $56 million, compared to $38 million in Q4 2023, marking an increase of 47.37%[60] - For the year ended December 31, 2024, business divestiture and integration costs were approximately $220 million and $5 million, respectively, compared to $108 million and $59 million in 2023[73]

Wall Street analysts expect International Flavors (IFF) to post quarterly earnings of $0.78 per share in its upcoming report, which indicates a year-over-year increase of 8.3%. Revenues are expected to be $2.67 billion, down 1.4% from the year-ago quarter.The consensus EPS estimate for the quarter has been revised 2.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a compan ...

International Flavors & Fragrances Inc. (IFF) is scheduled to report fourth-quarter 2024 results on Feb. 18, after the closing bell.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Zacks Consensus Estimate for IFF’s revenues is pegged at $2.67 billion, indicating a 1.37% dip from the year-ago reported figure.The consensus estimate for earnings is pegged at 78 cents per share. The consensus estimate for IFF’s earnings has moved down 2.5% in the past 60 days. The estimate indicates ...

International Flavors & Fragrances Inc. (IFF) is poised to gain from the end-market demand for flavors and fragrances. IFF’s initiatives are also expected to aid its performance. Improved volumes across all its segments in recent quarters will also drive the company’s performance.Let us delve deeper and analyze the factors that make International Flavors stock worth holding on to at present.Demand for Flavors & Fragrances Drives IFF’s GrowthInternational Flavors is well-poised to benefit from the demand for ...

Have you looked into how International Flavors (IFF) performed internationally during the quarter ending September 2024? Considering the widespread global presence of this ingredients producer for food, cosmetics and consumer products industries, examining the trends in international revenues is essential for assessing its financial resilience and prospects for growth.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its ...

International Flavors (IFF) has been beaten down lately with too much selling pressure. While the stock has lost 14.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillat ...

International Flavors & Fragrances Inc. (IFF) reported adjusted earnings of $1.04 per share in third-quarter 2024, missing the Zacks Consensus Estimate of $1.06 per share. However, the bottom line improved 17% from the year-ago quarter.Including one-time items, the company reported earnings of 23 cents per share compared with the prior-year quarter’s 10 cents per share.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.International Flavors’ net sales rose 3.7% year over year to $2.93 bi ...

Core Insights - International Flavors (IFF) reported revenue of $2.93 billion for the quarter ended September 2024, reflecting a year-over-year increase of 3.7% [1] - Earnings per share (EPS) for the quarter was $1.04, up from $0.89 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $2.83 billion by 3.25%, while the EPS fell short of the consensus estimate of $1.06 by 1.89% [1] Revenue Performance by Segment - Net Sales in the Nourish segment reached $1.49 billion, surpassing the average estimate of $1.44 billion, marking a 2.6% increase year-over-year [3] - Net Sales in the Scent segment were $613 million, slightly below the estimated $629.75 million, representing a minor decline of 0.3% compared to the previous year [3] - Net Sales in Pharma Solutions amounted to $256 million, exceeding the average estimate of $240.35 million, with a year-over-year growth of 7.6% [3] - Net Sales in Health & Biosciences reached $570 million, surpassing the estimated $531.83 million, reflecting a significant increase of 10% year-over-year [3] Adjusted Operating EBITDA Performance - Adjusted Operating EBITDA for the Nourish segment was $206 million, slightly below the estimate of $207.69 million [3] - Adjusted Operating EBITDA for Pharma Solutions was $62 million, exceeding the average estimate of $47.74 million [3] - Adjusted Operating EBITDA for the Scent segment was $127 million, falling short of the estimated $137.51 million [3] - Adjusted Operating EBITDA for Health & Biosciences was $173 million, surpassing the average estimate of $155.24 million [3] Stock Performance - Shares of International Flavors have returned -1.8% over the past month, compared to a -0.5% change in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [4]

Core Viewpoint - International Flavors (IFF) reported quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.06 per share, but showing an increase from $0.89 per share a year ago [1][2] Financial Performance - The company posted revenues of $2.93 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.25% and up from $2.82 billion year-over-year [3] - The earnings surprise for the quarter was -1.89%, while the previous quarter saw a positive surprise of 14.85% [2] Stock Performance - IFF shares have increased approximately 22.2% since the beginning of the year, outperforming the S&P 500's gain of 19.8% [4] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating expectations for outperformance in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.81 on revenues of $2.67 billion, and for the current fiscal year, it is $4.24 on revenues of $11.3 billion [8] - The estimate revisions trend for IFF is favorable, which could influence future stock movements [6][7] Industry Context - The Chemical - Specialty industry, to which IFF belongs, is currently ranked in the bottom 46% of over 250 Zacks industries, which may impact stock performance [9]